肉瘤新药他泽司他的治疗效果怎么样？可以使用医保购买吗？

The first histone methyltransferase (HMT) inhibitor on the market was the first EZH2 drug. In January 2020, tazerestat passed accelerated approval from the FDA for the treatment of adults and pediatric patients 16 years and older with metastatic/locally advanced epithelioid sarcoma who are not suitable for complete resection. Today, let’s learn more about the therapeutic effect of the new sarcoma drug tazerestat? Can I use medical insurance to purchase it?

Tazerestat is the first treatment option specifically for epithelioid sarcoma, a rare soft tissue sarcoma that tends to occur in younger adults. The trial study showed that patients receiving tazerestat 800 mg orally twice daily were evaluated for tumor response every 8 weeks. Results: Among a total of 62 patients treated, 1.6% of patients achieved complete response, 13% achieved partial response, and the overall response rate (ORR) was 15%. Of the 9 patients who responded, 6 (67%) had responses that lasted 6 months or longer. It can be seen that the effect of tazerestat in treating sarcoma is relatively good.

So, can tazerestat be purchased using medical insurance?

Since the drug is unmarketed in China, patients cannot purchase it in hospital pharmacies, let alone use it for reimbursement through medical insurance. Patients need to go abroad to purchase the drug, which imposes a heavy financial burden and is not suitable for patients to take the drug for a long time. It is recommended that patients obtain tazetostat through domestic professional overseas medical service institutions (such as Medical Companion Travel), which can save them the trouble of purchasing drugs abroad and reduce the financial burden on patients. The overseas versions of drugs obtained through Medical Companion Travel are directly mailed from pharmaceutical companies, which ensures that the drugs are genuine, the prices are more favorable, and they are cost-effective and suitable for patients to take drugs for a long time. For specific drug prices and drug purchase procedures, please consult the medical companion passenger service staff.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: